Models 4000/6000/8000/8900 Laser for Derma/Surgery
by Cooper Lasersonics, Inc. 510(k)
Active
510(k) K873790
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK873790 | Date22 Jan 1988 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- GEX
- Models / Variants
- Device Class
- Class II
- Regulation
- 21 CFR Part 878.4810
- Advisory Committee
- General, Plastic Surgery
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 24 Sep 2026
This device is a powered laser surgical instrument classified under the GEX product code, intended for use in general and plastic surgery applications. It encompasses the Models 4000, 6000, 8000, and 8900 laser systems designed for derma/surgery procedures.
The device received FDA 510(k) clearance under K873790 on January 22, 1988, as substantially equivalent to a predicate device. It is manufactured by Cooper Lasersonics, Inc. and is supplied as a reusable laser system for surgical use in clinical settings.
Other devices from Cooper Lasersonics, Inc.
Questions
AI-generated answers, 24 Sep 2026
What is the MODELS 4000/6000/8000/8900 Laser for Derma/Surgery used for?
This device is a powered laser surgical instrument intended for use in general and plastic surgery applications, specifically designed for derma/surgery procedures as indicated in its FDA 510(k) clearance.
Is the MODELS 4000/6000/8000/8900 Laser for Derma/Surgery reusable or single-use?
The device is supplied as a reusable laser system for surgical use in clinical settings, meaning it is designed for multiple uses after appropriate cleaning and sterilization between procedures.
What regulatory clearance does the MODELS 4000/6000/8000/8900 Laser for Derma/Surgery have?
The device received FDA 510(k) clearance under K873790 on January 22, 1988, as substantially equivalent to a predicate device, which is the regulatory pathway it followed for market authorization in the United States.